Archive · 29 Jan 2026
Spanish Team Cures Pancreatic Cancer in Mice
A Spanish scientist named Dr. Mariano Barbacid and his team have made a big discovery in fighting pancreatic cancer.
They used a special combination of three drugs to completely remove aggressive cancer tumours in mice.
This research was done at a famous cancer research centre in Spain and was checked by other experts to make sure it's good science.
Some people online are very excited about this news, while others are not so sure.
But many experts agree that this is one of the best signs yet that pancreatic cancer might be treated with the right mix of medicines.
The team got support for their work from a foundation that helps fight cancer.
This is an important step in finding better ways to treat this serious disease.
Dr. Mariano Barbacid's team eliminated aggressive pancreatic tumours in mice using a triple-drug therapy.
The research targeted the KRAS pathway, a known driver of pancreatic cancer.
The study was conducted at CNIO and supported by Fundación CRIS Contra el Cáncer.
Public reaction to the findings has been mixed, with both excitement and scepticism.
Experts agree that the work provides strong evidence for potential combination therapies in treating pancreatic cancer.
- Who
- Dr. Mariano Barbacid and his research team at CNIO
- What
- Successful elimination of aggressive pancreatic tumours in mice using a triple-drug therapy
- When
- The study was conducted and peer-reviewed, but the exact timeline is not specified
- Where
- At the Spanish National Cancer Research Centre (CNIO) in Spain
- Why
- To investigate potential treatments for pancreatic cancer by targeting the KRAS pathway
Optimists
Skeptics
Effectiveness of the Treatment
Optimists
The triple-drug therapy shows promise and could be a breakthrough in treating pancreatic cancer.
Skeptics
The treatment has only been tested in mice, and human trials are necessary to confirm its effectiveness.
Public Reaction
Optimists
The public is excited about the potential of this new treatment.
Skeptics
Some people remain skeptical due to the lack of human trials and the historical difficulty in treating pancreatic cancer.
- Scientist
- Dr. Mariano Barbacid
- Institution
- Spanish National Cancer Research Centre (CNIO)
- Funding
- Fundación CRIS Contra el Cáncer
- Research Focus
- Pancreatic cancer
- Method
- Triple-drug therapy targeting KRAS pathway
- Subjects
- Mice
- Publication
- Proceedings of the National Academy of Sciences (PNAS)
- Public Reaction
- Mixed (excitement to scepticism)
- Expert Consensus
- Strong indication for potential combination therapies
